Haisco Pharmaceutical Hits Day High with 7.46% Surge in Stock Price

Haisco Pharmaceutical Group Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.46% on March 27, 2026. The stock reached an intraday high of CNY 55.70, showcasing its strong activity in the market. This performance stands in contrast to the China Shanghai Composite, which only saw a modest increase of 0.63% on the same day. Over the past week, Haisco has outperformed the broader market with an 8.05% gain, while the composite index declined by 1.09%. The company's one-month performance is particularly noteworthy, with an 18.2% increase compared to a 5.99% decrease in the composite index. Year-to-date, Haisco has maintained a positive trajectory, rising 7.44% against the composite's decline of 1.39%. In terms of long-term performance, Haisco has shown impressive growth, with a 134.64% increase over the past three years and a remarkable 238.07% rise over the last decade. Despite these gains, the company faces challenges with a relatively high price-to-earnings ratio of 141.00 and a return on equity of 7.32%.